HIV/Aids

09 May 2007

Clinton clinches Aids deal

The Clinton Foundation announced Tuesday that it has reached agreements with drug companies to reduce the costs of some HIV/Aids drugs in developing countries.

0
The Clinton Foundation announced Tuesday that it has reached agreements with drug companies to reduce the costs of some HIV/Aids drugs in developing countries.

The foundation said drug makers agreed to lower the price of drugs to fight HIV that is resistant to initial treatment, and to make a once-a-day HIV/Aids pill available for less than $1 a day, the Associated Press reported.

The deals on the drugs to fight resistant HIV, reached with generic drug makers Cipla Ltd. and Matrix Laboratories Ltd., are expected to achieve average savings of 50 percent in middle-income countries and 25 percent in low-income countries, said former US President Bill Clinton.

The agreement on the $1 once-a-day pills that combine the drugs efavirenz, lamivudine and tenofovir is 45 percent less than the current rate available for low-income countries and 67 percent less than the current price for many middle-income countries, the AP reported. – (HealthDayNews)

Read more:
HIV/Aids Centre

May 2007

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

HIV/Aids expert

Dr Sindisiwe van Zyl qualified at the University of Pretoria in 2005. She is a patients' rights activist and loves using social media to teach about HIV. She is in private practice in Johannesburg.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules